Consistently, increased colonic activity of estrogen-activating or estrogen-converting enzymes in CRC patients and tissue samples leading to estrogen-mediated GPER1 activation was associated with increased CRC cell proliferation via GPER1 (48). Here, GPER1 is linked to colorectal carcinoma.